Advertisement

Complement Receptor Type 1 (C3b/C4b Receptor; CD35) and Complement Receptor Type 2 (C3d/Epstein-Barr Virus Receptor; CD21)

  • D. T. Fearon
  • J. M. Ahearn
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 153)

Abstract

The primary sequence of the A allotype of CR1 has been deduced from the cDNA sequence and includes a 41-residue signal peptide, an extracellular domain of 1930 residues, a 25 amino acid transmembrane domain, and a 43 amino acid cytoplasmic region (WONG et al 1985; KLICKSTEIN et al. 1987,1988; HOURCADE et al. 1988) (Fig. 1). Thirty short consensus repeats (SCRs) similar to those present in other C3/C4 binding complement proteins comprise the extracellular domain. Each SCR has four cysteines which may be disulfide bonded in the pattern, cysteine-1 to cysteine-3 and cysteine-2 to cysteine-4 (LOZIER et al. 1984; Janatova et al. 1988). These disulfide bridges create three loops of 26-29 amino acids, 12-19 amino acids, and 12-16 amino acids, respectively, in CR1. The dimensions of each SCR in CR1, 2.9 x 2.8 nm, have been estimated by electron microscopy (BARTOW et al. 1989) and are comparable to those of the SCRs of C4 binding protein (C4-bp; PERKINS et al. 1986). The regions linking SCRs are short, ranging from three to five amino acids, except for that connecting SCR-28 to SCR-29 which is seven amino acids in length. This characteristic may limit the range of motion between SCRs, perhaps accounting for the filamentous appearance of CR1.

Keywords

Membrane Cofactor Protein Short Consensus Repeat Binding Complement Protein Nussenzweig Versus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abrahamson DR, Fearon DT (1983) Endocytosis of the C3b receptor of complement within coated pits in human polymorphonuclear leukocytes and monocytes. Lab Invest 48:162–168PubMedGoogle Scholar
  2. Ahearn JM, Hayward SD, Hickey JC, Fearon DT (1988) Epstein-Barr virus (EBV) infection of murine L cells expressing recombinant human EBV/C3d receptor. PTOC Natl Acad Sci USA 85: 9307–9311Google Scholar
  3. Alsenz J, Schulz TF, Lambris JD, Sim RB, Dierich MP (1985) Structural and functional analysis of the complement component factor H with the use of different enzymes and monoclonal antibodies to factor H. Biochem J 232: 841–850PubMedGoogle Scholar
  4. Appay MD, Mounier F, Gubler MC, Rouchon M, Beziau A, Kazatehkine MD (1985) Ontogenesis of the glomerular C3b receptor (CR1) in fetal human kidney. Clin Immunol Immunopathol 37: 103PubMedGoogle Scholar
  5. Atkinson JP, Jones EA (1984) Biosynthesis of the human C3b/C4b receptor during differentiation of the HL-60 cell line. Identification and characterization of a precursor molecule. J Clin Invest 74: 1649PubMedGoogle Scholar
  6. Barel M, Fiandino A, Delcayre AX, Lyamani F, Frade R (1988) Monoclonal and anti-idiotypic anti-EBV/C3d receptor antibodies detect two binding sites, one for EBV and one for C3d on glycoprotein 140, the EBV/C3dR, expressed on human B lymphocytes. J Immunol 141: 1590–1595PubMedGoogle Scholar
  7. Barnum S, Kenney J, Kristensen T, Noack D, Seldon M, D’Eustachio P, Chaplin D, Tack B (1987) Chromosomal location and structure of the mouse C4BP gene. Complement 4: 131Google Scholar
  8. Bartow T, Klickstein L, Wong W, Roux K, Fearon D (1989) Analysis of the tertiary structure of CR1 by electron microscopy. FASEB J 3: A501Google Scholar
  9. Bohnsack JF, Cooper NR (1988) CR2 ligands modulate human B cell activation. J Immunol 141:2569–2576PubMedGoogle Scholar
  10. Bora NS, Lublin DM, Kumar BV, Hockett RD, Holers VM, Atkinson JP (1989) Structural gene for human membrane cofactor protein (MCP) of complement maps to within 100 kb of 373x2032; end of the C3b/C4b receptor gene. J Exp Med 169: 597–602PubMedGoogle Scholar
  11. Bottger EC, Hoffman T, Hadding U, Bitter-Suermann D (1985) Influence of genetically inherited complement deficiencies on humoral immune response in guinea pigs. J Immunol 135: 4100–4107PubMedGoogle Scholar
  12. Carroll MC, Alicot EA, Katzman PJ, Klickstein LB, Smith JA, Fearon DT (1988) Organization of the gene encoding complement receptors type 1 and 2, decay accelerating factor and C4-binding protein in the RCA locus on human chromosome 1. J Exp Med 167: 1271PubMedGoogle Scholar
  13. Carter RH, Spycher MO, Ng YC, Hoffman R, Fearon DT (1988) Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes. J Immunol 141:457–463PubMedGoogle Scholar
  14. Changelian PS, Fearon DT (1986) Tissue-specific phosphorylation of complement receptors CR1 and CR2. J Exp Med 163: 101–115PubMedGoogle Scholar
  15. Chevalier J, Kazatchkine MD (1989) Distribution in clusters of complement receptor type one (CR1) on human erythrocytes. J Immunol 142: 2031–2036PubMedGoogle Scholar
  16. Cohen JHM, Aubry JP, Kazatchkine MD, Banchereau J, Revillard JP (1987) CRl-bearing human T cells are exclusively found with the CD4 + subset (Abstract). Complement 4:143Google Scholar
  17. Daha MR, Bloem AC, Ballieux RE (1984) Immunoglobulin production by human peripheral lymphocytes induced by anti-C3 receptor antibodies. J Immunol 132: 1197–1201PubMedGoogle Scholar
  18. Dykman TR, Cole JL, Iida K, Atkinson JP (1983) Polymorphism of human erythrocyte C3b/C4b receptor. Proc Natl Acad Sci USA 80: 1698–1702PubMedGoogle Scholar
  19. Dykman TR, Hatch JA, Atkinson JP (1984) Polymorphism of the human C3b/C4b receptor. Identification of a third allele and analysis of receptor phenotypes in families and patients with systemic lupus erythematosus. J Exp Med 159: 691–703PubMedGoogle Scholar
  20. Dykman TR, Hatch JA, Aqua MS, Atkinson JP (1985) Polymorphism of the C3b/C4b receptor (CR1): characterization of a fourth allele. J Immunol 134: 1787–1789PubMedGoogle Scholar
  21. Eden A, Miller GW, Nussenzweig V (1973) Human lymphocytes bear membrane receptors for C3b and C3d. J Clin Invest 52: 3239–3242PubMedGoogle Scholar
  22. Emancipator SN, Iida K, Nussenzweig V, Gallo GR (1983) Monoclonal antibodies to human complement receptor CR1) detect defects in glomerular diseases. Clin Immunol Immunopa-thol 27: 170–175Google Scholar
  23. Erdei A, Melchers F, Schulz T, Dierich M (1985) The action of human C3 in soluble or cross-linked form with resting and activated murine B lymphocytes. Eur J Immunol 15: 184–188PubMedGoogle Scholar
  24. Fearon DT (1979) Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from the human erythrocyte membrane. Proc Natl Acad Sci USA 76: 5867–5871PubMedGoogle Scholar
  25. Fearon DT (1980) Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte. J Exp Med 152: 20–30PubMedGoogle Scholar
  26. Fearon DT, Collins LA (1983) Increased expression of C3b receptors on polymorphonuclear leukocytes induced by chemotactic factors and by purification procedures. J Immunol 130: 370–375PubMedGoogle Scholar
  27. Fearon DT, Kaneko I, Thomson GG (1981) Membrane distribution and adsorptive endocytosis by C3b receptors on human polymorphonuclear leukocytes. J Exp Med 153: 1615–1628PubMedGoogle Scholar
  28. Fingeroth JD, Weis JJ, Tedder TF, Strominger JL, Biro PA, Fearon DT (1984) Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci USA 81:4510–4514PubMedGoogle Scholar
  29. Fingeroth JD, Clabby ML, Strominger JD (1988) Characterization of a T-lymphocyte Epstein-Barr virus/C3d receptor (CD21). J Virol 62: 1442–1447PubMedGoogle Scholar
  30. Fingeroth JD, Benedict MA, Levy DN, Strominger JL (1989) Identification of murine complement receptor type 2. Proc Natl Acad Sci USA 86: 242–246PubMedGoogle Scholar
  31. Frade R (1986) Structure and functions of gp 140, the C3d/EBV receptor (CR2) of human B lymphocytes. Mol Immunol 23: 1249–1253PubMedGoogle Scholar
  32. Frade R, Crevon MC, Barel M, Vazquez A, Krikorian L, Charriaut C, Galanaud P (1985) Enhancement of human B cell proliferation by an antibody to the C3d receptor, the gp 140 molecule. Eur J Immunol 15: 73–76PubMedGoogle Scholar
  33. Fujisaku A, Harley JB, Frank MB, Grüner BA, Frazier B, Holers VM (1989) Genomic organization and polymorphisms of the human C3d/Epstein-Barr virus receptor. J Biol Chem 264:2118–2125PubMedGoogle Scholar
  34. Gelfand MC, Fran MM, Green I (1975) A receptor for the third component of complement in the human renal glomerulus. J Exp Med 142: 1029–1034PubMedGoogle Scholar
  35. Hatzfeld A, Fischer E, Levesque J-P, Perrin R, Hatzfeld J, Kazatchkine MD (1988) Binding of C3 and C3dg to the CR2 complement receptor induces growth of an Epstein-Barr virus-positive human B cell line. J Immunol 140: 170–175PubMedGoogle Scholar
  36. Holers VM, Chaplin DD, Leykam JF, Grüner BA, Kumar V, Atkinson JP (1987) Human complement C3b/C4b receptor (CR1) mRNA polymorphism that correlates with the CR1 allelic molecular weight polymorphism. Proc Natl Acad Sci USA 84: 2459PubMedGoogle Scholar
  37. Hourcade D, Miesner DR, Atkinson JP, Holers VM (1988) Identification of an alternative polyadenylation site in the human C3b/C4b receptor (complement receptor type 1) transcriptional unit and prediction of a secreted form of complement receptor type 1. J Exp Med 168: 1255–1270PubMedGoogle Scholar
  38. Hunter T, Cooper JA (1985) Protein-tyrosine kinases. Annu Rev Biochem 54: 897–930PubMedGoogle Scholar
  39. Iida K, Nadler L, Nussenzweig V (1983) Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody. J Exp Med 158:1021–1033PubMedGoogle Scholar
  40. Jack RM, Fearon DT (1988) Selective synthesis of mRNA and protein by human peripheral blood neutrophils. J Immunol 140: 4286–4293PubMedGoogle Scholar
  41. Jackson CG, Ochs HD, Wedgwood RJ (1979) Immune response of a patient with deficiency of the fourth component of complement and systemic lupus erythematosus. N Engl J Med 300: 1124–1129PubMedGoogle Scholar
  42. Janatova J, Reid KBM, Willis AC (1988) Involvement of disulfide bonds in the structure of complement regulatory protein C4bp. FASEB J 2: A1832Google Scholar
  43. Kazatchkine MD, Fearon DT, Appay MD, Mandet C, Bariety J (1982) Immunohistochemical study of the human glomerular C3b receptor in normal kidney and in seventy-five cases of renal diseases. J Clin Invest 69: 900–912PubMedGoogle Scholar
  44. Kishimoto A, Nishiyama K, Nakanishi H, Uratsuji Y, Nomura H, Takeyama Y, Nishizuka Y (1985) Studies on the phosphorylation of myelin basic protein by protein kinase C and adenosine 3′:5′-monophosphate-dependent protein kinase. J Biol Chem 260: 12492–12499PubMedGoogle Scholar
  45. Klaus GGB, Humphrey JH (1977) The generation of memory cells. I. The role of C3 in the generation of B memory cells. Immunology 33: 31–40PubMedGoogle Scholar
  46. Klickstein LB, Wong WW, Smith JA, Weis JH, Wilson JG, Fearon DT (1987) Human C3b/C4b receptor (CR1): demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristics of C3/C4 binding proteins. J Exp Med 165: 1095–1112PubMedGoogle Scholar
  47. Klickstein LB, Bartow TJ, Miletic V, Rabson LD, Smith JA, Fearon DT (1988) Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CRI, CD35) by deletion mutagenesis. J Exp Med 168: 1699–1717PubMedGoogle Scholar
  48. Kristensen T, D′Eustachio P, Ogata RT, Chung LP, Reid KBM, Tack BF (1987) The superfamily of C3b/C4b binding proteins. Fed Proc 46: 2463–2469PubMedGoogle Scholar
  49. Lambris JD, Ganu VS, Hirani S, Müller-Eberhard HJ (1985) Mapping of the C3d receptor (CR2)-binding site and a neoantigenic site in the C3d domain of the third component of complement. Proc Natl Acad Sci USA 82: 4235–4239PubMedGoogle Scholar
  50. Lozier J, Takahaski N, Putnam FW (1984) Complete amino acid sequence of human plasma β2-glycoprotein I. Proc Natl Acad Sci USA 81: 3640–3645PubMedGoogle Scholar
  51. Lublin DM, Griffith RC, Atkinson JP (1986) Influence of glycosylation on allelic and cell-specific Mr variation, receptor processing, and ligand binding of the human complement C3b/C4b receptor. J Biol Chem 261: 5736PubMedGoogle Scholar
  52. Lublin DM, Lemona RS, LeBeau MM, Holers VM, Tykocinski ML, Medof ME, Atkinson JP (1987) The gene encoding decay-accelerating factor (DAF) is located in the complement-regulatory locus on the long arm of chromosome 1. J Exp Med 165: 1731PubMedGoogle Scholar
  53. Melchers F, Erdei A, Schulz T, Dierich MP (1985) Growth control of activated, synchronized murine B cells by the C3d fragment of human complement. Nature 317: 264–267PubMedGoogle Scholar
  54. Menezes J, Scigneurin JM, Patel P, Bourkas A, Lenoir G (1977) Presence of Epstein-Barr virus receptors, but absence of virus penetration, in cells of an Epstein-Barr virus genome-negative human lymphoblastoid T line (Molt4). J Virol 22: 816–821PubMedGoogle Scholar
  55. Mittler RS, Talle Ma, Carpenter K, Rao PE, Goldstein G (1983) Generation and characterization of monoclonal antibodies reactive with human B lymphocytes. J Immunol 131:1754–1761PubMedGoogle Scholar
  56. Mold C, Cooper NR, Nemerow GR (1986) Incorporation of the purified Epstein-Barr virus/C3d receptor (CR2) into liposomes and demonstration of its dual ligang binding functions. J Immunol 136: 4140–4145PubMedGoogle Scholar
  57. Moore MD, Cooper NR, Tack BF, Nemerow GR (1987) Molecular cloning of the cDNA encoding the Epstein-Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytes. Proc Natl Acad Sci USA 84: 9194–9198PubMedGoogle Scholar
  58. Nadler LM, Stashenko, P, Hardy R, van Agthoven A, Terhorst C, Schlossman SF (1981) Characterization of a human B cell-specific antigen (B2) distinct from Bl. J Immunol 126: 1941–1947PubMedGoogle Scholar
  59. Nemerow GR, McNaughton ME, Cooper NR (1985a) Binding of monoclonal antibody to the Epstein-Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes. J Immunol 135: 3068–3073PubMedGoogle Scholar
  60. Nemerow GR, Wolfert R, McNaughton ME, Cooper NR (1985b) Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2). J Virol 55: 347–351PubMedGoogle Scholar
  61. Nemerow GR, Mold C, Schwend VK, Tollefson V, Cooper NR (1987) Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d. J Virol 61: 1416–1420PubMedGoogle Scholar
  62. Nemerow GR, Hough ten RA, Moore MD, Cooper NR (1989) Identification of an epitope in the major envelope protein of Epstein-Barr virus that mediates viral binding to the B lymphocyte EBV receptor (CR2). Cell 56: 369–377PubMedGoogle Scholar
  63. Neuman E, Jack RM (1989) Transcription and translation of CR1 and class I by neutrophils (PMN) increases with GM-CSF. FASEB J 3: A368Google Scholar
  64. Nickells MW, Seya T, Holers VM, Atkinson JP (1986) Analysis of C3b/C4b receptor (CR1) polymorphic variants by tryptic peptide mapping. Mol Immunol 23: 661–668PubMedGoogle Scholar
  65. Nunez D, Charriaut-Marlangue C, Barel M, Benveniste J, Frade R (1987) Activation of human platelets through gpl40, the C3d/EBV receptor (CR2). Eur J Immunol 17: 515–520PubMedGoogle Scholar
  66. O’Neil KM, Ochs HD, Heller SR, Cork LC, Morris JM, Winkelstein JA (1988) Role of C3 in humoral immunity. Defective antibody production in C3-deficient dogs. J Immunol 140: 1939–1945PubMedGoogle Scholar
  67. Perkins SJ, Chung LP, Reid KB (1986) Unusual ultrastructure of complement-component-C4b-binding protein of human complement by synchrotron X-ray scattering and hydrodynamic analysis. Biochem J 233(3): 799–807PubMedGoogle Scholar
  68. Pernegger G, Schulz TF, Hosp M, Myones BL, Petzer AL, Eigentier A, Bock G, Wick G, Dierich MP (1988) Cell cycle control of a Burkitt lymphoma cell line: responsiveness to growth signals engaging the C3d/EBV receptor. Immunology 65: 237–241PubMedGoogle Scholar
  69. Rao PE, Wright SD, Westberg EF, Goldstein G (1985) OKB7, a monoclonal antibody that reacts at or near the C3d binding site of human CR2. Cell Immunol 93: 549–555PubMedGoogle Scholar
  70. Rey-Campos J, Rubinstein P, Rodriguez de Cordoba S (1987) Decay-accelerating factor genetic polymorphism and linkage to RCA (regulator of complement activation) gene cluster in humans. J Exp Med 166: 246PubMedGoogle Scholar
  71. Rey-Campos J, Rubinstein P, Rodriguez de Cordoba S (1988) A physical map of the human regulator of complement activation gene cluster linking the complement genes CRI, CR2, DAF and C4bp. J Exp Med 167: 664PubMedGoogle Scholar
  72. Reynes M, Aubert JP, Cohen JHM, Audouin J, Tricotet V, Diebold J, Kazatchkine MD (1985) Human follicular dendritic cells express CRI, CR2 and CR3 complement receptor antigens. J Immunol 135: 2687–2694PubMedGoogle Scholar
  73. Rodriguez de Cordoba S, Rubinstein P (1986) Quantitative variations of the C3b/C4b receptor (CR1) in human erythrocytes are controlled by genes within the regulator of complement activation (RCA) gene cluster. J Exp Med 164: 1274–1283Google Scholar
  74. Rodriguez de Corboda S, Rubinstein P (1987) New alleles of C4-binding protein and factor H and further linkage data in the regulator of complement activation (RCA) gene cluster in man. Immunogenetics 25: 267Google Scholar
  75. Rodriguez de Cordoba S, Dykman TR, Ginsberg-Fellner F, Ercilla G, Aqua M, Atkinson JP, Rubinstein P (1984) Evidence for linkage between the loci coding for the binding protein for the fourth component of human complement (C4BP) and for the C3b/C4b receptor. Proc Natl Acad Sci USA 81: 7890–7892Google Scholar
  76. Rodriguez de Cordoba S, Lublin DM, Rubinstein P, Atkinson JP (1985) Human genes for three complement components that regulate the activation of C3 are tightly linked. J Exp Med 161: 1189–1195Google Scholar
  77. Ross GD, Polley MJ, Rabellino EM, Grey HM (1973) Two different complement receptors on human lymphocytes. One specific for C3b and one specific for C3b inactivator-cleaved C3b. J Exp Med 138:798–811PubMedGoogle Scholar
  78. Sixbey JW, Lemon SM, Pagano JS (1986) A second site for Epstein-Barr virus shedding: the uterine cervix. Lancet 2: 1122–1124PubMedGoogle Scholar
  79. Sixbey JW, Davis DS, Young LS, Hutt-Fletcher L, Tedder TF, Rickinson AB (1987) Human epithelial cell expression of an Epstein-Barr virus receptor. J Gen Virol 68: 805–811PubMedGoogle Scholar
  80. Tanner, J, Weis J, Fearon D, Whang Y, Kieff E (1987) Epstein-Barr virus gp350/220 binding to CR2 on the B lymphocyte mediates adsorption, capping and endocytosis. Cell 50:203–213PubMedGoogle Scholar
  81. Tanner J, Whang Y, Sample J, Sears A, Kieff E (1988) Soluble gp 350/220 and deletion mutant glycoproteins block Epstein-Barr virus adsorption to lymphocytes. J Virol 62: 4452–4464PubMedGoogle Scholar
  82. Tatsumi E, Harada S, Kuszynski C, Volsky D, Minowada J, Purtilo DT (1985) Catalogue of Epstein-Barr virus (EBV) receptors on human malignant and nonmalignant hematopoietic cell lines. Leuk Res 9: 231–238PubMedGoogle Scholar
  83. Tedder TF, Fearon DT, Gartland GL, Cooper MD (1983) Expression of C3b receptors on human B cells and myelomonocytic cells but not natural killer cells. J Immunol 130: 1668–1673PubMedGoogle Scholar
  84. Tedder TF, Clement LT, Cooper MD (1984) Expression of C3d receptors during human B cell differentiation: immunofluorescence analysis with the HB-5 monoclonal antibody. J Immunol 133: 678–683PubMedGoogle Scholar
  85. Tedder TF, Weis JJ, Clement LT, Fearon DT, Cooper MD (1986) The role of receptors for complement in the induction of polyclonal B-cell proliferation and differentiation. J Clin Immunol 6: 65–73PubMedGoogle Scholar
  86. Tsokos GC, Thyphronitis G, Jack RM, Finkelman FD (1988) Ligand-loadded but not free complement receptors for C3b/C4b and C3d co-cap with cross-linked B cell surface IgM and IgD. J Immunol 141: 1261–1266PubMedGoogle Scholar
  87. Tsoukas CD, Lambris JD (1988) Expression of CR2/EBV receptor on human thymocytes detected by monoclonal antibodies. Eur J Immunol 18: 1299–1302PubMedGoogle Scholar
  88. van Dyne S, Holers VM, Lublin DM, Atkinson JP (1987) The polymorphism of the C3b/C4b receptor in the normal population and in patients with systemic lupus erythematosus. Clin Exp Immunol 68: 570PubMedGoogle Scholar
  89. Vik DP and Fearon DT (1987) Cellular distribution of complement receptor type 4 (CR4): expression on human platelets. J Immunol 138: 254–258PubMedGoogle Scholar
  90. Vik DP, Keeney JB, Bronson S, Westlund B, Kristensen T, Chaplin DD, Tack BF (1987) Analysis of the murine factor H gene and related DNA. Complement 4: 235Google Scholar
  91. Vik DP, Keeney JB, Chaplin DD, Tack BF (1988) Structure of the murine factor H gene. FASEB J 2: A1643Google Scholar
  92. Weis JH, Morton CC, Bruns GAP, Weis JJ, Klickstein LB, Wong WW, Fearon DT (1987) A complement receptor locus: genes encoding C3b/C4b receptor and C3d/Epstein-Barr virus receptor map to Iq32. J Immunol 138: 312–315PubMedGoogle Scholar
  93. Weis JJ, Fearon DT (1985) The identification of N-linked oligosaccharides on the human CR2/Epstein-Barr virus receptor and their function in receptor metabolism, plasma membrane expression, and ligand binding. J Biol Chem 260: 13824–13830PubMedGoogle Scholar
  94. Weis JJ, Tedder TF, Fearon DT (1984) Identification of a 145000Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes. Proc Natl Acad Sci USA 81: 881–885PubMedGoogle Scholar
  95. Weis JJ, Fearon DT, Klickstein LB, Wong WW, Richards SA, de Bruyn Kops A, Smith JA, Weis JH (1986) Identification of a partial cDNA clone for the C3d/Epstein-Barr virus receptor of human B lymphocytes: homology with the receptor for fragments C3b and C4b of the third and fourth components of complement. Proc Natl Sci USA 83: 5639–5643Google Scholar
  96. Weis JJ, Toothaker LE, Smith JA, Weis JH, Fearon DT (1988) Structure of the human B lymphocyte receptor for C3d and the Epstein-Barr virus and relatedness to other members of the family of C3/C4 binding proteins. J Exp Med 167: 1047–1066PubMedGoogle Scholar
  97. Weiss L, Del Fraissy J-F, Vazquez A, Wallon C, Galanaud P, Kazatchkine MD (1987) Monoclonal antibodies to the human C3b/C4b receptor (CR1) enhance specific B cell differentiation. J Immunol 138: 2988–2993PubMedGoogle Scholar
  98. Wilson BS, Platt JL, Kay NE (1985) Monoclonal antibodies to the 140000 mol wt glycoprotein of B lymphocyte membranes (CR2 receptor) initiates proliferation of B cells in vitro. Blood 66: 824–829PubMedGoogle Scholar
  99. Wilson JG, Wong WW, Schur PH, Fearon DT (1982) Mode of inheritance of decreased C3b receptors on erythrocytes of patients with systemic lupus erythematosus. N Engl J Med 307: 981–986PubMedGoogle Scholar
  100. Wilson JG, Tedder TF, Fearon DT (1983) Characterization of human T lymphocytes that express the C3b receptor. J Immunol 131: 684–689PubMedGoogle Scholar
  101. Wilson JG, Murphy EE, Wong WW, Klickstein LB, Weis JH, Fearon DT (1986) Identification of a restriction fragment length polymorphism by a CR1 cDNA that correlates with the number of CR1 on erythrocytes. J Exp Med 164: 50–59PubMedGoogle Scholar
  102. Wong WW, Wilson JG, Fearon DT (1983) Genetic regulation of a structural polymorphism of human C3b receptor. J Clin Invest 72: 685–693PubMedGoogle Scholar
  103. Wong WW, Klickstein LB, Smith JA, Weis JH, Fearon DT (1985) Identification of a partial cDNA clone for the human receptor for complement fragments C3b/C4b. Proc Natl Acad Sci USA 82: 7711–7715PubMedGoogle Scholar
  104. Wong WW, Kennedy CA, Bonaccio ET, Wilson JG, Klickstein LB, Weis JH, Fearon DT (1986) Analysis of multiple restriction fragment length polymorphisms of the gene for the human complement receptor type 1: duplication of genomic sequences occurs in association with a high molecular weight receptor allotype. J Exp Med 164: 1531–1546PubMedGoogle Scholar
  105. Wong WW, Cahill JM, Rosen MD, Kennedy CA, Bonaccio ET, Morris MJ, Wilson JG, Klickstein LB, Fearon DT (1989) Structure of the human CR1 gene: molecular basis of the structural and quantitative polymorphisms and identification of a new CRl-like allele. J Exp Med 169: 847–864PubMedGoogle Scholar
  106. Yoon SH, Fearon DT (1985) Characterization of a soluble form of the C3b/C4b receptor (CR1) inhuman plasma. J Immunol 134: 3332–3333PubMedGoogle Scholar
  107. Young LS, Clark D, Sixbey JW, Rickinson AB (1986) Epstein-Barr virus receptors on human pharyngeal epithelia. Lancet 1: 240–242PubMedGoogle Scholar
  108. Yu GH, Holers M, Seya T, Ballard L, Atkinson JP (1986) Identification of a third component-binding glycoprotein of human platelets. J Clin Invest 78: 494–501PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • D. T. Fearon
    • 1
  • J. M. Ahearn
    • 1
  1. 1.Department of Medicine and The Graduate Program in ImmunologyThe Johns Hopkins University School of MedicineBaltimoreUSA

Personalised recommendations